Treat so Deep Acne-Fighting Treatment

Description

The product identified by SPL code 34089-3 is designated as 01b UC_Treat So Deep. Further details regarding its chemical composition, molecular weight, and dosage form are not provided in the extracted facts.

Uses and Indications

This drug is indicated for the treatment of acne, specifically to help clear existing acne blemishes and to prevent the formation of new acne lesions, including blackheads and whiteheads.

There are no teratogenic effects associated with this drug, and no nonteratogenic effects have been reported.

Dosage and Administration

Healthcare professionals are advised to ensure that the skin is thoroughly cleaned prior to the application of this product. The recommended application involves covering the entire affected area with a thin layer. This should be done one to three times daily, depending on the patient's needs and the physician's guidance.

To minimize the risk of excessive drying of the skin, it is recommended to initiate treatment with a once-daily application. If necessary, the frequency may be gradually increased to twice daily, based on the patient's response and as directed by a healthcare provider. In cases where bothersome dryness or peeling occurs, it is advisable to reduce the application frequency to once daily or every other day to alleviate these symptoms.

Contraindications

There are no contraindications associated with the use of this product. It is not classified as a controlled substance, and there are no known risks of abuse, misuse, or dependence. Additionally, there are no specific instructions indicating that the product should not be taken or used under any circumstances.

Warnings and Precautions

The product is intended for external use only. It is imperative to keep the formulation away from open fire or flame, as it is flammable.

Healthcare professionals should advise patients to avoid contact with the eyes. In the event of accidental contact, it is crucial to flush the eyes thoroughly with water to mitigate any potential irritation.

Patients using this product should be cautioned that skin irritation and dryness may be exacerbated if another topical acne medication is used concurrently. To minimize the risk of irritation, it is recommended that only one topical acne medication be utilized at a time.

Additionally, this product must be kept out of reach of children. In the case of ingestion, immediate medical assistance should be sought, or contact with a poison control center should be made without delay.

Side Effects

Patients using this product should be aware that it is for external use only and is flammable; therefore, it must be kept away from open fire or flame.

During the use of this product, it is crucial to avoid contact with the eyes. In the event of contact, patients should flush the eyes thoroughly with water.

Skin irritation and dryness have been reported as common adverse reactions, particularly when this product is used concurrently with other topical acne medications. If patients experience irritation, it is recommended that they discontinue the use of other topical acne treatments and limit the use to one topical acne medication at a time to mitigate these effects.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications should be considered to alleviate symptoms. Monitoring for signs of skin irritation is recommended when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Treat so Deep Acne-Fighting Treatment (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or a poison control center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

The safety of this product during pregnancy has not been established. The use of salicylic acid during pregnancy is generally contraindicated due to potential risks to the fetus. There may be a risk of teratogenic effects associated with the use of salicylic acid in pregnant individuals. Therefore, pregnant women should consult a healthcare provider before using this product to discuss potential risks and benefits.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or any lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. Further research may be necessary to fully understand the implications for breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdose, it is imperative to seek immediate medical assistance or contact a Poison Control Center without delay. Prompt intervention is crucial to mitigate potential adverse effects associated with the overdose.

Healthcare professionals are advised to monitor the patient closely for any symptoms that may arise as a result of the overdose. The specific symptoms can vary depending on the substance involved, and timely recognition of these symptoms is essential for effective management.

Management procedures should be initiated as per established protocols for overdose cases, which may include supportive care and symptomatic treatment. It is vital to follow local guidelines and recommendations for the management of overdose situations to ensure patient safety and optimal outcomes.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. Instruct patients that if the medication is swallowed, they should seek medical help immediately or contact a poison control center for assistance. It is essential for patients to understand the importance of these precautions to ensure their safety and the safety of others.

Storage and Handling

The product is supplied in configurations that include specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at room temperature to maintain its integrity and effectiveness. Care should be taken to keep the product away from open fire or flame to prevent any potential hazards. Additionally, once opened, the product must be discarded to ensure safety and efficacy.

Additional Clinical Information

The route of administration for the medication is topical, with a recommendation to cover the entire affected area with a thin layer one to three times daily. Patients should start with once daily application, gradually increasing to twice daily if necessary or as directed by a clinician. In cases of bothersome dryness or peeling, it is advised to reduce the application frequency to once daily or every other day.

Clinicians should counsel patients to avoid contact with the eyes, and in the event of contact, to flush thoroughly with water. The likelihood of skin irritation and dryness increases if another topical acne medication is used concurrently; therefore, it is recommended to use only one topical acne medication at a time. A patch test is also suggested before introducing a new product into the skincare routine, which involves applying a small amount to a clean area of skin and monitoring for any adverse reactions over 24 hours.

Drug Information (PDF)

This file contains official product information for Treat so Deep Acne-Fighting Treatment, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)